Baxter International Inc.

Baxter International is a global medical products company that develops, manufactures, and markets pharmaceuticals, medical devices, and biotechnology products. A significant portion of its product portfolio, including injectable drugs, renal therapies, and surgical sealants, falls under regulatory frameworks that mandate animal testing for safety and efficacy prior to human clinical trials. The company’s products are routinely cited in published biomedical research as the standard supplies used in animal models, indicating Baxter’s role as a provider to the research industry.

The company’s operations are directly integrated into the animal testing ecosystem. Academic and industry studies, such as those published in Springer and PubMed Central, explicitly list “Baxter International Inc.” as the source for saline solutions and other compounds administered to laboratory animals. This demonstrates that Baxter’s products are not only developed using animal data but are also essential consumables in ongoing animal research conducted by others. While some testing may be required for regulatory compliance, the company’s broad and sustained involvement across the pharmaceutical and medical device sectors places it at the center of this activity.